According to a market report by Lucintel, the future of the global endoluminal suturing device market looks promising with opportunities in the hospital, clinic, and ambulatory surgical center markets. The global endoluminal suturing device market is expected to reach an estimated $1 billion by 2030 at a CAGR of 11.5% from 2024 to 2030. The major drivers for this market are growing number of gastrointestinal cancers, increasing preference for minimally invasive weight loss surgeries, and rising incidence of obesity.
A more
than 150-page report to understand trends, opportunity and forecast in global endoluminal suturing device market to 2030 by application (bariatric surgery,
gastrointestinal surgery, gastroesophageal reflux disease surgery, and others),
end use (hospitals, clinics, ambulatory surgical centers, and others), and
region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel
forecasts that gastrointestinal surgery will remain the largest segment due to
its growing usage in the treatment of gastrointestinal cancers and
gastrointestinal disorders.
Hospital
will remain the largest segment due to rising demand for endoluminal suturing
devices in this setting by skilled healthcare professionals for the treatment
of patients undergoing bariatric procedures or chronic diseases.
Download
sample by clicking on endoluminal
suturing device market.
North
America will remain the largest region due to existenc of well-established
healthcare system, growing volume of surgical operations, and presence of key
players in the region.
Apollo
Endosurgery, Johnson & Johnson, Medtronic, Cook, USGI Medical, Ovesco
Endoscopy, Endo Tools Therapeutics, Ergosuture, Sutrue are the major suppliers
in the endoluminal suturing
device market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
No comments:
Post a Comment